
Listing in the Medical Aid Catalogue (Hilfsmittelverzeichnis): Market Access in Germany
How sananet supports your reimbursement strategy according §139 SGB V
Germany is Europe’s largest healthcare market, yet its strict reimbursement system often poses a major hurdle for international medical device manufacturers. While sananet helps you connect with Key Opinion Leaders (KOLs), distributors, and strategic partners, securing reimbursement is often the critical first step for commercial success—especially in the growing home care sector.
Which Products Need a Medical Aid Code (Hilfsmittelnummer)?
In Germany, statutory health insurances (Gesetzliche Krankenversicherung – GKV) cover costs strictly by sector. Medical devices intended for home use by patients are often classified as medical aids (Hilfsmittel).
To qualify for reimbursement under § 33 SGB V (German Social Code, Book V), these products must be listed in the official Medical Aid Catalogue (Hilfsmittelverzeichnis – HMV) and receive a specific 10-digit code (Hilfsmittelnummer). This catalogue is managed by the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband).
Which Products Need a Medical Aid Code (Hilfsmittelnummer)?
In Germany, statutory health insurances (Gesetzliche Krankenversicherung – GKV) cover costs strictly by sector. Medical devices intended for home use by patients are often classified as medical aids (Hilfsmittel).
To qualify for reimbursement under § 33 SGB V (German Social Code, Book V), these products must be listed in the official Medical Aid Catalogue (Hilfsmittelverzeichnis – HMV) and receive a specific 10-digit code (Hilfsmittelnummer). This catalogue is managed by the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband).
How sananet Guides You Through the Application Process
Because a rejection from the GKV-Spitzenverband makes future applications significantly harder, thorough preparation is essential. Through our specialized Reimbursement for Remedies and Aids consulting, sananet follows a proven, step-by-step process to maximize your chances of success:
Step 1: Initial Reimbursement & Portfolio Assessment
First, we evaluate whether your product portfolio qualifies for reimbursement under § 33 SGB V today. If you offer multiple devices, we analyze how they fit into the existing HMV structure and whether they can be grouped under a single product category (Produktgruppe / Produktart) or code.
- Milestone: A strategic roadmap outlining the reimbursement potential for each product segment.
Step 2: Gap Analysis & Strategy Definition (Under the Radar)
Before contacting the authorities, we conduct a detailed analysis for each product segment. We determine whether to apply under an existing HMV category or if a new category must be established to reflect your product’s Unique Selling Proposition (USP).
To meet the requirements of § 139 SGB V, we review your documentation against the core GKV criteria:
- Functionality (Funktionstauglichkeit): Does the device reliably perform its intended function?
- Safety (Sicherheit): Is safety proven via valid CE marking under the EU MDR and corresponding certificates?
- Quality (Qualitätsanforderungen): Does the device meet the specific technical and quality standards of the relevant product group?
- Medical Benefit (Medizinischer Nutzen): Is there objective clinical evidence (e.g., cure rates, reduced side effects, or lower recurrence rates) proving that the device cures a disease, compensates for a disability, or improves health?
- Intended Use (Zweckbestimmung): We align your application strictly with the indications for which you hold complete clinical and technical proof. (Note: While not an official criterion, authorities also evaluate the overall cost-benefit ratio.)
Up to this point, we operate completely “under the radar” without alerting the GKV-Spitzenverband.
- Milestone: A tailored application strategy choosing one of three regulatory pathways:
- Pathway A (Existing Comparable Product): A competitor’s product is already listed with a Hilfsmittelnummer. This allows for a structured, standard application.
- Pathway B (Existing Category, Novel Product): Your product fits an existing HMV category, but no comparable device is listed yet. This requires stronger clinical evidence and health economic data.
- Pathway C (No Fitting Category): No suitable category exists, or major regulatory obstacles apply. This leads to a lengthy process, often requiring a formal assessment by the Federal Joint Committee (Gemeinsamer Bundesausschuss – G-BA). In such cases, we also evaluate alternative reimbursement routes.
Step 3: Dossier Preparation & GKV Application
We only submit the application once all required documents are complete and verified. Depending on your chosen pathway, sananet manages the entire dossier compilation and takes over direct communication via the official GKV Online Application Portal:
- In Pathway A: Once complete documentation is submitted, the GKV is legally required under 139 Abs. 6 SGB V to decide within three months (though follow-up questions from the authorities typically extend this timeframe).
- In Pathways B & C: Timelines vary significantly depending on the complexity of the clinical data required and the extent of authority reviews.
Additional Market Access Services by sananet
Explore our full range of Medical Technology Consulting Competencies to accelerate your market entry:
- Clinical Evidence & KOL Network: If you lack local data to prove medical benefit, we help you find German KOLs and reference sites to conduct field tests or clinical studies.
- Pharmacy Distribution (PZN): If you plan to distribute your medical device through German pharmacies, we manage the application for the Central Pharmaceutical Number (Pharmazentralnummer – PZN).
Quick Glossary: Key German Reimbursement Terms
| German Term / Abbreviation | Meaning & Relevance |
| G-BA (Gemeinsamer Bundesausschuss) | Federal Joint Committee – The highest decision-making body of the joint self-government of physicians, dentists, hospitals, and health insurance funds in Germany. |
| GKV (Gesetzliche Krankenversicherung) | Statutory Health Insurance – Public health insurance covering approximately 90% of the German population. |
| GKV-Spitzenverband | National Association of Statutory Health Insurance Funds – The central federal association responsible for managing and updating the Hilfsmittelverzeichnis. |
| Hilfsmittel | Medical Aid – Devices, appliances, or technical aids used by patients at home to ensure medical treatment success, prevent disability, or compensate for impairments. |
| Hilfsmittelnummer | Medical Aid Code – A unique 10-digit code assigned to a product upon listing in the HMV, required for billing statutory health insurances. |
| Hilfsmittelverzeichnis (HMV) | Medical Aid Catalogue – The official directory of reimbursable medical aids in Germany, structured by product groups (Produktgruppen). |
| KOL (Key Opinion Leader) | Leading Medical Specialists – Physicians or clinical institutions whose evaluations and field tests support market acceptance and reimbursement. |
| PZN (Pharmazentralnummer) | Central Pharmaceutical Number – A standardized 8-digit identification code mandatory for distributing medical devices or pharmaceuticals via German pharmacies. |
| SGB V (Sozialgesetzbuch V) | German Social Code, Book V – The statutory legal framework governing Germany’s statutory health insurance system (including § 33 for entitlement to aids and § 139 for the HMV). |
Ready to evaluate your product’s reimbursement potential in Germany?
Contact us at info@sananet.com or visit www.sananet.com to schedule an initial consultation.

Contact
info@sananet.com
+49 (0)451 40 08 300

